Article Text

Download PDFPDF

125 A case of multiple paraneoplastic syndromes associated with CRMP5 antibodies and lung cancer
  1. Ahmad Alareed1,
  2. Rebecca Broad1,
  3. Oliver Cousins2,
  4. Deepthi Changaradil3,
  5. Ian Redmond1,
  6. Lorena Flores Caimanque1
  1. 1East Kent Hospitals University Foundation Trust
  2. 2Kings College Hospital NHS Foundation Trust
  3. 3Dartford and Gravesham NHS Trust

Abstract

The collapsin response-mediator protein-5 (CRMP5) autoantibody is a recognised biomarker for small cell lung cancer associated neurological Paraneoplasia.

We describe a 79-year-old lady, who presented with right hemi-chorea. This progressed over one month, becoming bilateral and rendering the patient bedbound.

MRI revealed bilateral signal change within the caudate and lentiform nuclei. CT chest detected mediastinal lymphadenopathy, while PET identified pulmonary malignancy with radiological staging T1bN3M0. Serum CRMP5 antibodies were positive.

Haloperidol and intravenous methylprednisolone lead to some improvement in Chorea and mobility. However, visual acuity deteriorated to finger counting. Fundoscopy revealed mild cataracts, while visual evoked potentials were very delayed on the right and absent on the left, suggesting optic neuropathy.

She deteriorated with leg pain, weakness, and loss of tendon reflexes, as well as cognitive decline and visual hallucinations. Clinically this raised suspicion of radiculoneuropathy and encephalopathy respectively. Whilst retaining capacity the patient refused further investigations and treatment. She was discharged to a nursing home and died 6 months later.

CRMP5 antibodies, targeting intracellular antigens, precipitate an onconeuronal autoimmune process through mechanisms not fully understood. We report a case of combined chorea, optic neuropathy, peripheral neuropathy, and encephalopathy, which highlights the potential for CRMP5 to cause multifocal neurological dysfunction.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.